Download PDF
Exp Clin Endocrinol Diabetes 2017; 125(01): e2
DOI: 10.1055/a-1736-9432
Expression of concern

Expression of concern: A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight Type 2 Diabetic Patients with Coronary Heart Disease

Authors

  • M. Tajabadi-Ebrahimi

    1   Faculty Member of Science Department, Science Faculty, Islamic Azad University, Tehran Central branch, Tehran, Iran

  • N. Sharifi

    2   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • A. Farrokhian

    3   Department of Cardiology, School of Medicine, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • F. Raygan

    3   Department of Cardiology, School of Medicine, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • F. Karamali

    4   Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

  • R. Razzaghi

    5   Department of Infectious Disease, school of medicine, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • S. Taheri

    2   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • Z. Asemi

    2   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran
Further Information
Also available at
   Permissions and Reprints

This Expression of Concern relates to:

A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight Type 2 Diabetic Patients with Coronary Heart DiseaseExp Clin Endocrinol Diabetes 2017; 125(01): 21-27
DOI: 10.1055/s-0042-105441

A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight Type 2 Diabetic Patients with Coronary Heart Disease

Tajabadi-Ebrahimi M et al. Exp Clin Endocrinol Diabetes 2017; 125 DOI 10.1055/s-0042-105441

10.1055/s-0042-105441

Since publication of this article, serious concerns have been raised about the integrity of the reported methods, results and analysis. Responses by the leading author and ethics committees have been unsatisfactory and inconclusive; we advise readers to interpret the information presented in the article with due caution.



Publication History

Article published online:
25 January 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany